Copyright (c) 1997 Elsevier Science B.V. All rights reserved.
A questionnaire was distributed in early 1996 to 160 leading European neurological, neuro-pediatric and neurosurgical centers to assess the present status of Moyamoya disease in Europe.
The response rate was 43%. Information was obtained on a total of 168 patients, of whom 110 had presented before 1992, and 58 from 1993 onward. 82% of the patients were Caucasian.
In all other respects, the clinical findings were similar to those observed in Japan.
The present study yields an incidence of 0.3 patients per center per year, which is approximately one-tenth of the incidence in Japan.
Alongside these results, the history of the recognition and treatment of this disease in Europe is briefly discussed. 1997 Elsevier Science B.V.
Mots-clés Pascal : Nishimoto Kudo maladie, Europe, Etat actuel, Ethnie, Caucasoïde, Incidence, Epidémiologie, Evolution, Homme, Encéphale pathologie, Système nerveux pathologie, Système nerveux central pathologie, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Cérébrovasculaire pathologie
Mots-clés Pascal anglais : Nishimoto Kudo disease, Europe, State of the art, Ethnic group, Caucasoid, Incidence, Epidemiology, Evolution, Human, Cerebral disorder, Nervous system diseases, Central nervous system disease, Cardiovascular disease, Vascular disease, Cerebrovascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0006960
Code Inist : 002B17C. Création : 17/04/1998.